Viridian Therapeutics' Q3 Net Loss Widens as Revenue Falls
Viridian Therapeutics reported a wider net loss and lower revenue in Q3.
Related stories
UK New-Car Sales Rise 26.9% Year Over Year in October
UK total new-car sales reached 154,407 units in October, up 26.9% year over year, according to new automotive data.
M impact | EQUITY | Nov 04, 2026, 03:02 PM UTC
Marcopolo Reports Lower Third-Quarter Net Profit
Marcopolo reported a decline in net profit in 3Q26.
M impact | EQUITY | Nov 04, 2026, 02:51 PM UTC
Marcopolo Q3 Net Profit Falls 43.4% to R$186.5 Million
M impact | EQUITY | Nov 04, 2026, 02:51 PM UTC
Safehold Publishes Q3 2026 Earnings Call Transcript
M impact | EQUITY | Nov 04, 2026, 02:50 PM UTC
Trading Resumes in Anteros Metals
Trading in Anteros Metals Inc. (ANT) has resumed.
L impact | EQUITY | Nov 04, 2026, 02:49 PM UTC
Electrolux halves planned redundancies in Italy
Electrolux has halved the number of redundancies under its revised industrial plan in Italy.
M impact | EQUITY | Nov 04, 2026, 02:49 PM UTC